During the past decade, Samaritan North Health Center conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 61 clinical trials were completed, i.e. on average, 321.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 29 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Samaritan North Health Center" #1 sponsor was "National Cancer Institute (NCI)" with 34 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "ETOP IBCSG Partners Foundation" with 5 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samaritan North Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 36 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Samaritan North Health Center" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Adult Glioblastoma" (4 trials), "Adult Gliosarcoma" (4 trials) and "Breast Cancer" (4 trials). Many other conditions were trialed in "Samaritan North Health Center" in a lesser frequency.

Most popular intervention types in "Samaritan North Health Center" are "Drug" (66 trials), "Other" (40 trials), "Biological" (28 trials), "Procedure" (9 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Bevacizumab" (10 trials), "Pharmacological Study" (9 trials), "Quality-of-Life Assessment" (8 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Samaritan North Health Center" are 58 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Samaritan North Health Center". undefined are not yet recruiting, undefined are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Samaritan North Health Center, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Samaritan North Health Center, 4 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".